Changes Dec. 14, 2020
The following is a list of changes on monitored regulatory lists which occurred between Dec. 10, 2020 and Dec. 14, 2020.
Legend
- regulatory records added to the list
- regulatory records removed from the list
- changed regulatory records
For changed records, you can see the history of changes by following the link to the corresponding regulatory record.
Registry of CLH intentions until outcome
- 1,3-bis(1-isocyanato-1-methylethyl)benzene
- 1,3-bis(isocyanatomethyl)benzene
- 1,5-naphthylene diisocyanate
- 2,2-dimethylpropan-1-ol, tribromo derivative; 3-bromo-2,2-bis(bromomethyl)propan-1-ol
- 2,4,6-tri-tert-butylphenol
- 2,4,6-triisopropyl-m-phenylene diisocyanate
- 2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether
- 2-(2-methoxyethoxy)ethanol
- 2-amino-3-chloro-1,4-naphthoquinone
- 2-ethyl-2-[[(1-oxoallyl)oxy]methyl]-1,3-propanediyl diacrylate; 2,2-bis(acryloyloxymethyl)butyl acrylate; trimethylolpropane triacrylate
- 2-ethylhexanoic acid, manganese salt
- 2-ethylhexanoic acid, molybdenum salt
- 2-ethylhexanoic acid, zirconium salt
- 4,4'-isopropylidenediphenol
- 4,4'-oxydi(benzenesulphonohydrazide)
- Ammonium bromide
- Barium bis(2-ethylhexanoate)
- Barium diboron tetraoxide
- Benzophenone
- Calcium bis(2-ethylhexanoate)
- Cumene
- Daminozide
- Dibutyltin bis(2-ethylhexanoate)
- Dibutyltin di(acetate)
- Exo-1,7,7-trimethylbicyclo[2.2.1]hept-2-yl acrylate
- Hexanoic acid, 2-ethyl-, zinc salt, basic
- Hexyl salicylate
- Metal salts of 2-ethylhexanoic acid
- Methyl methacrylate
- N-(2-nitrophenyl)phosphoric triamide
- N-(5-chloro-2-isopropylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide; isoflucypram
- Potassium 2-ethylhexanoate
- Pyridine-2-thiol 1-oxide, sodium salt
- Silanamine, 1,1,1-trimethyl-N-(trimethylsilyl)-, hydrolysis products with silica
- Sodium 2-ethylhexanoate
- Tellurium
- Tellurium dioxide
- Theophylline
- Zinc bis(2-ethylhexanoate)
- acetamiprid (ISO); (1E)-N-[(6-chloropyridin-3-yl)methyl]-N'-cyano-N-methylethanimidamide; (E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine
- beta-cyfluthrin (ISO); reaction mass of rel-(R)-cyano(4-fluoro-3-phenoxyphenyl)methyl (1S,3S)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate and rel-(R)-cyano(4-fluoro-3-phenoxyphenyl)methyl (1S,3R)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate (ratio 1:2)
- clofentezine (ISO); 3,6-bis(o-chlorophenyl)-1,2,4,5-tetrazine
- cymoxanil (ISO); 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)acetamide
- dimoxystrobin (ISO); (2E)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide; (E)-2-(methoxyimino)-N-methyl-2-[a-(2,5-xylyloxy)-o-tolyl]acetamide
- fluopicolide (ISO); 2,6-dichloro-N-[3-chloro-5-(trifluoromethyl)-2-pyridylmethyl]benzamide
- pendimethalin (ISO); N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidene
- picolinafen (ISO); N-(4-fluorophenyl)-6-[3-(trifluoromethyl)phenoxy]pyridine-2-carboxamide; 4′-fluoro-6-[(α,α,α-trifluoro-m-tolyl)oxy]picolinanilide
- pyridalyl (ISO); 2,6-dichloro-4-(3,3-dichloroallyloxy)phenyl 3-[5-(trifluoromethyl)-2-pyridyloxy]propyl ether
- α-cyano-4-fluoro-3-phenoxybenzyl 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate